Linking immune cell kinetics and clinical scores to dose and retreat timing in autoimmunity, sharpening endpoint selection

Mapping early oncology kinetics to response and event management, improving cohort design and monitoring

Distilling predictive versus misleading preclinical readouts, streamlining data packages for efficiency